- Home
- TLPH vs SSKN Comparison
TLPH vs SSKN Comparison
Compare TLPH & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- SSKN
- Stock Information
- Founded
- TLPH 2005
- SSKN 1989
- Country
- TLPH United States
- SSKN United States
- Employees
- TLPH N/A
- SSKN N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- SSKN Medical/Dental Instruments
- Sector
- TLPH Health Care
- SSKN Health Care
- Exchange
- TLPH Nasdaq
- SSKN Nasdaq
- Market Cap
- TLPH 13.4M
- SSKN 13.5M
- IPO Year
- TLPH 2011
- SSKN 2005
- Fundamental
- Price
- TLPH $0.73
- SSKN $3.07
- Analyst Decision
- TLPH Strong Buy
- SSKN
- Analyst Count
- TLPH 2
- SSKN 0
- Target Price
- TLPH $4.50
- SSKN N/A
- AVG Volume (30 Days)
- TLPH 67.4K
- SSKN 14.3K
- Earning Date
- TLPH 11-13-2024
- SSKN 11-13-2024
- Dividend Yield
- TLPH N/A
- SSKN N/A
- EPS Growth
- TLPH N/A
- SSKN N/A
- EPS
- TLPH N/A
- SSKN N/A
- Revenue
- TLPH $281,000.00
- SSKN $32,674,999.00
- Revenue This Year
- TLPH N/A
- SSKN $0.14
- Revenue Next Year
- TLPH N/A
- SSKN $12.67
- P/E Ratio
- TLPH N/A
- SSKN N/A
- Revenue Growth
- TLPH N/A
- SSKN N/A
- 52 Week Low
- TLPH $0.61
- SSKN $2.51
- 52 Week High
- TLPH $1.61
- SSKN $7.00
- Technical
- Relative Strength Index (RSI)
- TLPH 35.76
- SSKN 49.49
- Support Level
- TLPH $0.66
- SSKN $2.92
- Resistance Level
- TLPH $0.73
- SSKN $3.10
- Average True Range (ATR)
- TLPH 0.08
- SSKN 0.22
- MACD
- TLPH -0.02
- SSKN -0.01
- Stochastic Oscillator
- TLPH 15.55
- SSKN 38.96
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.